Clozapine, used for the management of treatment-resistant schizophrenia, is subject to strict regulatory and monitoring requirements.

New research has found that ibuprofen and paracetamol may contribute to antimicrobial resistance – particularly when used in combination.

After the most severe influenza year this century, ATAGI outlines key vaccine updates and timing guidance for pharmacists.

The Australian Health Practitioner Regulation Agency has debuted a new platform that many pharmacists have found less than user friendly.

The RSV vaccination will soon be funded for older Australians on the National Immunisation Program (NIP) to ensure protection.

Simple compounding has long been a part of pharmacists’ scope of practice, but new guidelines have opened up the potential for complex compounding. For some patients,...